Affiliation: F. Hoffmann-La Roche Ltd
- Safety and pharmacology of oseltamivir in clinical useRegina Dutkowski
Hoffmann La Roche, Nutley, New Jersey 07110, USA
Drug Saf 26:787-801. 2003..To conclude, no important safety concerns have evolved which might limit the suitability of oseltamivir for the treatment and prevention of influenza in all patient populations...
- Oseltamivir in seasonal influenza: cumulative experience in low- and high-risk patientsRegina Dutkowski
Clinical Development Virology, Hoffmann La Roche Inc, 340 Kingsland Street, Nutley, NJ 07110 1199, USA
J Antimicrob Chemother 65:ii11-ii24. 2010..Oseltamivir-susceptible pandemic (H1N1) 2009 viruses now predominate in many countries. Oseltamivir is generally well tolerated, with a similar adverse event profile to placebo...
- Oseltamivir (Tamiflu) and its potential for use in the event of an influenza pandemicPenelope Ward
Roche Products Ltd, Welwyn Garden City, Herts, UK
J Antimicrob Chemother 55:i5-i21. 2005..In the absence of a stockpile, there is no guarantee that an adequate supply of oseltamivir will be available...